Medical devices, healthcare technology and the business of care
510(k) clearance · K262731

Virata Spinal Fixation System

SeaSpine Orthopedics Corporation · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK262731

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 29, 2026 for K262731, a traditional 510(k) from SeaSpine Orthopedics Corporation for the Virata Spinal Fixation System, a Class II thoracolumbosacral pedicle screw system under 21 CFR 888.3070 with product codes NKB, KWP and OLO. The application was received July 31, 2026. SESE is a clearance finding, not a PMA approval.

The submission's stated purpose was to add lateral offset, parallel connectors and a navigated instrument to the Virata system, which uses modular and preassembled screws with solid or cannulated shanks and rods in multiple lengths, diameters and materials. The summary lists K250908 as primary predicate and K132014, K172517 and K232566 as additional predicates, and cites MR artifact and RF heating testing under ASTM F2119-07 and ASTM F2182-19E2. The source does not give clinical performance data, and the public record does not state whether the added components were separately reviewed.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262731
Regulatory pathway
510(k) premarket notification
Product code
NKB
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Product code
NKB
FDA device class
2

FDA decision timeline

  1. K262731 received

    Application receipt date recorded by FDA.

  2. K262731 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA
Rivarp Medical Pvt., Ltd.510(k) clearanceSep 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SeaSpine Orthopedics Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Carlsbad, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records